Literature DB >> 15454920

Toll-like receptors in the pathogenesis of human disease.

Donald N Cook1, David S Pisetsky, David A Schwartz.   

Abstract

Members of the Toll-like receptor (TLR) family are key regulators of both innate and adaptive immune responses. The function of TLRs in various human diseases has been investigated by comparison of the incidence of disease among people having different polymorphisms in genes that participate in TLR signaling. These studies have shown that TLR function affects several diseases, including sepsis, immunodeficiencies, atherosclerosis and asthma. As this body of data grows, it will provide new insights into disease pathogenesis as well as valuable information on the merits of various therapeutic options.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15454920     DOI: 10.1038/ni1116

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  252 in total

1.  A single nucleotide polymorphism in 3'-untranslated region contributes to the regulation of Toll-like receptor 4 translation.

Authors:  Kayo Sato; Atsutoshi Yoshimura; Takashi Kaneko; Takashi Ukai; Yukio Ozaki; Hirotaka Nakamura; Xinyue Li; Hiroyoshi Matsumura; Yoshitaka Hara; Yorimasa Ogata
Journal:  J Biol Chem       Date:  2012-06-01       Impact factor: 5.157

2.  Bacterial DNA induces pulmonary damage via TLR-9 through cross-talk with neutrophils.

Authors:  Kiyoshi Itagaki; Yasaman Adibnia; Shiqin Sun; Cong Zhao; Tolga Sursal; Yu Chen; Wolfgang Junger; Carl J Hauser
Journal:  Shock       Date:  2011-12       Impact factor: 3.454

3.  Toll-like receptor signaling during myocardial ischemia.

Authors:  Tobias Eckle; Holger K Eltzschig
Journal:  Anesthesiology       Date:  2011-03       Impact factor: 7.892

4.  The critical role of IL-1 receptor-associated kinase 4-mediated NF-κB activation in modified low-density lipoprotein-induced inflammatory gene expression and atherosclerosis.

Authors:  Tae Whan Kim; Maria Febbraio; Peggy Robinet; Brandon Dugar; Diane Greene; Anna Cerny; Eicke Latz; Raymond Gilmour; Kirk Staschke; Guy Chisolm; Paul L Fox; Paul E DiCorleto; Jonathan D Smith; Xiaoxia Li
Journal:  J Immunol       Date:  2011-01-28       Impact factor: 5.422

5.  Population growth and allergen accumulation of Dermatophagoides pteronyssinus cultured at 20 and 25 °C.

Authors:  Lakshmi Yella; Marjorie S Morgan; Larry G Arlian
Journal:  Exp Appl Acarol       Date:  2010-09-14       Impact factor: 2.132

Review 6.  Structural insights into the assembly of large oligomeric signalosomes in the Toll-like receptor-interleukin-1 receptor superfamily.

Authors:  Ryan Ferrao; Jixi Li; Elisa Bergamin; Hao Wu
Journal:  Sci Signal       Date:  2012-05-29       Impact factor: 8.192

Review 7.  Microbiome-intestine cross talk during acute graft-versus-host disease.

Authors:  Hind Rafei; Robert R Jenq
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

8.  T helper 1 cells stimulated with ovalbumin and IL-18 induce airway hyperresponsiveness and lung fibrosis by IFN-gamma and IL-13 production.

Authors:  Nobuki Hayashi; Tomohiro Yoshimoto; Kenji Izuhara; Kiyoshi Matsui; Toshio Tanaka; Kenji Nakanishi
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-31       Impact factor: 11.205

9.  Expression and function of dectin-1 is defective in monocytes from patients with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Claudia Salazar-Aldrete; Marta Galán-Díez; Elena Fernández-Ruiz; Perla Niño-Moreno; Lizbeth Estrada-Capetillo; Carlos Abud-Mendoza; Esther Layseca-Espinosa; Lourdes Baranda; Roberto González-Amaro
Journal:  J Clin Immunol       Date:  2012-10-25       Impact factor: 8.317

10.  The neuropeptide calcitonin gene-related peptide causes repression of tumor necrosis factor-alpha transcription and suppression of ATF-2 promoter recruitment in Toll-like receptor-stimulated dendritic cells.

Authors:  Felicitas Altmayr; Gabriela Jusek; Bernhard Holzmann
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.